Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The management of severe pre-eclampsia and eclampsia

B M Hibbard, M Rosen

    British Journal of Anaesthesia
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A plan for the NHS for the 21st century.

    Anaesthesia·2000
    Same author

    Regional anaesthesia--awake or asleep?

    Anaesthesia·2000
    Same author

    Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95. Results from the national AMI register in Sweden.

    Journal of internal medicine·2000
    Same author

    DNA structures common for chironomid telomeres terminating with complex repeats.

    Insect molecular biology·2000
    Same author

    What is the "golden standard" for assessing population-based interventions?--problems of dilution bias.

    Journal of epidemiology and community health·2000
    Same author

    Alzheimer's disease and anaesthesia.

    Anaesthesia·2000

    Severe pre-eclampsia and eclampsia management requires coordinated obstetric and anesthetic care. This guide outlines drug therapy, including diazepam, pethidine, and hydralazine, for hypertension and seizures.

    Area of Science:

    • Obstetrics and Gynecology
    • Anesthesiology
    • Critical Care Medicine

    Background:

    • Improving antenatal care reduces severe pre-eclampsia and eclampsia incidence, leading to decreased clinical experience.
    • Effective management necessitates collaborative planning between obstetricians and anesthesiologists.
    • A standardized therapeutic regimen is crucial for managing these high-risk obstetric conditions.

    Purpose of the Study:

    • To provide a comprehensive drug therapy protocol for severe pre-eclampsia and eclampsia.
    • To guide clinicians in managing acute complications such as hypertension, seizures, and fluid imbalances.
    • To ensure coordinated care through teamwork between obstetric and anesthetic departments.

    Main Methods:

    • Initial management involves intravenous diazepam and pethidine for sedation and analgesia, or extradural blocks.

    Related Experiment Videos

  • Hydralazine is administered intravenously to control diastolic blood pressure below 110 mm Hg, with continuous infusion as needed.
  • Subsequent management includes continued sedation, anticonvulsant therapy (chlormethiazole for severe cases), and adjustment of hydralazine dosage.

    • Main Results:

    • The protocol addresses hypertension, seizures, vomiting (with atropine), tachycardia (with propranolol), and plasma protein depletion (with albumin).
    • Diuretic therapy (frusemide) is indicated for edema or renal failure signs, with mannitol for cerebral edema.
    • Management of electrolyte imbalances (potassium) and disseminated intravascular coagulation (heparin) is also detailed.

    Conclusions:

    • A coordinated, team-based approach utilizing a defined drug regimen is essential for managing severe pre-eclampsia and eclampsia.
    • This protocol provides a structured framework for addressing critical aspects of patient care, from initial stabilization to subsequent management.
    • Maintaining vigilance and adapting therapy based on patient response are key to optimizing outcomes in these obstetric emergencies.